SHARE

Consumer Healthcare And Emerging Markets Help GSK Return To Growth

Britain’s biggest pharmaceutical firm has posted a 4% rise in third-quarter sales compared to the same period last year, reaching £7.1bn. GlaxoSmithKline saw particularly strong growth in sales for its consumer brands, such as Sensodyne, as well as in emerging markets.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.